Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

Publication Type:

Journal Article


Journal of the National Cancer Institute, Volume 103, Issue 20, p.1498-506 (2011)


2011, November 2011, Public Health Sciences Division


Among patients with resected colon cancer, black patients have worse survival than whites. We investigated whether disparities in survival and related endpoints would persist when patients were treated with identical therapies in controlled clinical trials.